Kenneth Ramos | |
---|---|
Born | |
Academic background | |
Education | BS, University of Puerto Rico MD, University of Louisville Health Sciences Center PhD, University of Texas at Austin |
Thesis | Sequence of myocardial alterations induced by isoproterenol in primary cultures of rat heart cells (1983) |
Academic work | |
Institutions | Texas A&M University University of Arizona |
Kenneth S. Ramos is an American physician-scientist.
Ramos received his undergraduate degree from the University of Puerto Rico,his medical degree from the University of Louisville Health Sciences Center,and his Ph.D. from the University of Texas at Austin. [1]
Following his PhD,Ramos joined the University of Louisville Health Sciences Center where he served as a distinguished scholar and professor in the Department of Biochemistry and Molecular Biology. In 2014,he joined the University of Arizona as their Associate Vice President for Precision Health Sciences at the Arizona Health Sciences Center. [1] The following year,he was elected a member of the National Academy of Medicine for his research in genomics and predictive biology,environmental and molecular medicine,and toxicology. [2] He remained at the University of Arizona until 2019 when he accepted an appointment as executive director of the Institute of Biosciences and Technology in Houston and assistant vice chancellor for Health Services at the Texas A&M University System. [3]
Ramos and his wife Irma have two children together. [4]
Ferid Murad was an American physician and pharmacologist,and a co-winner of the 1998 Nobel Prize in Physiology or Medicine.
Marco A. Marra is a Distinguished Scientist and Director of Canada's Michael Smith Genome Sciences Centre at the BC Cancer Research Centre and Professor of Medical Genetics at the University of British Columbia (UBC). He also serves as UBC Canada Research Chair in Genome Science for the Canadian Institutes of Health Research and is an inductee in the Canadian Medical Hall of Fame. Marra has been instrumental in bringing genome science to Canada by demonstrating the pivotal role that genomics can play in human health and disease research.
The Texas A&M Institute of Biosciences and Technology (IBT),a component of Texas A&M Health,and The Texas A&M University System,is located in the world's largest medical center,the Texas Medical Center,in Houston,Texas. The institute provides a bridge between Texas A&M University System scientists and other institutions' researchers working in the Texas Medical Center and the biomedical and biotechnology research community in Houston. It emphasizes collaboration between member scientists and others working in all the fields of the biosciences and biotechnology. IBT encourages its scientists to transfer discoveries made in their laboratories to the clinic and marketplace.
George Henry Poste,CBE FRS,is a former Director of the Biodesign Institute at Arizona State University.
Texas A&M Health,also known as Texas A&M University Health,and Texas A&M University Health Science Center,is the medical education component of Texas A&M University,and offers health professions research,education and patient care in dentistry,medicine,nursing,biomedical sciences,public health,and pharmacy on its several campuses. One of the fastest-growing academic health centers in the nation,Texas A&M Health encompasses six schools and numerous centers and institutes. It was established in 1999 as an independent institution of the Texas A&M University System and received accreditation in December 2002 from the Southern Association of Colleges and Schools to award baccalaureate,master's,doctoral and professional degrees. The institution and its colleges merged with Texas A&M University on July 12,2013.
Kenneth Blum is an American scientist who has studied neuropsychopharmacology and genetics. Until 1995 he was a professor of Pharmacology at the University of Texas Health Science Center at San Antonio.
David Mark Hillis is an American evolutionary biologist,and the Alfred W. Roark Centennial Professor of Biology at the University of Texas at Austin. He is best known for his studies of molecular evolution,phylogeny,and vertebrate systematics. He created the popular Hillis Plot depiction of the evolutionary tree of life.
Joe G. N. "Skip" Garcia is an American pulmonary scientist,physician and academician.
Santiago Schnell FRSB FRSC is a scientist and academic leader,currently serving as the William K. Warren Foundation Dean of the College of Science at the University of Notre Dame,as well as a professor in the Department of Biological Sciences,and Department of Applied and Computational Mathematics and Statistics.
Trey Ideker is a professor of medicine and bioengineering at UC San Diego. He is the Director of the National Resource for Network Biology,the San Diego Center for Systems Biology,and the Cancer Cell Map Initiative. He uses genome-scale measurements to construct network models of cellular processes and disease.
The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS),is a joint venture of the University of Texas Health Science Center at Houston and the University of Texas MD Anderson Cancer Center. It offers Ph.D. and M.S. degrees in many areas of study,and a M.D./Ph.D. program in collaboration with McGovern Medical School at UTHealth Houston,and it is fully accredited by the Southern Association of Colleges and Schools through both its parent institutions,UTHealth and MD Anderson. It is located in the heart of the Texas Medical Center.
Harold C. Smith Jr. is an American scientist,researcher,professor,founder and CEO of OyaGen. Smith has written over 100 publications on his research in RNA editing,AIDS,oncology,and immunodeficiency,among others.
Jason X.-J. Yuan is an American physician scientist whose research interests center on pulmonary vascular pathobiology and pulmonary hypertension. His current research is primarily focused on the pathogenic mechanisms of pulmonary vascular diseases and right heart failure.
Shahid Jameel is an Indian virologist and academic. Dr. Jameel is the Sultan Qaboos bin Said Fellow at Oxford Centre for Islamic Studies and Research Fellow,Green Templeton College,University of Oxford. He serves as the Principal Investigator for the Centre's project on Public Health,Science and Technology in Muslim societies. Previously he was the director of the Trivedi School of Biosciences since its inception in the year 2020 at Ashoka University. He was formerly head of the scientific advisory group to the Indian SARS-CoV-2 Genomics Consortia (INSACOG) established in December 2020,and the chief executive officer of Wellcome Trust DBT India Alliance. Known for his research in hepatitis E virus,Jameel is an elected fellow of all the three major Indian science academies viz. National Academy of Sciences,India,Indian Academy of Sciences,and Indian National Science Academy. The Council of Scientific and Industrial Research,the apex agency of the Government of India for scientific research,awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology,one of the highest Indian science awards for his contributions to Medical Sciences in 2000.
Jochen Reiser is a physician-scientist and a healthcare leader. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System,which includes the oldest Medical School and Nursing School in the state of Texas. As Chief Executive Officer,he oversees the enterprise which includes multiple campuses,five health science colleges,the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas. Before UTMB,he served as the Ralph C Brown MD Professor and the Chairman of Medicine at Rush University Medical Center. Dr. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Dr. Reiser discovered the role of suPAR as a global,circulating risk factor for chronic kidney disease (CKD) as well as for acute kidney injury (AKI). suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS). These studies have broad clinical significance and lay the foundation for creation of novel diagnostics and pharmaco-therapeutics with potential benefit for a large patient population. His studies on suPAR molecule were featured in Science in 2018. Dr. Reiser has been an advocate of science and innovation for two decades and was named as an inventor on multiple patents. He is co-founder of Cambridge,MA-based Walden Biosciences,an ARCH Venture Partners joint-venture biopharmaceutical portfolio company dedicated to develop first-in-class therapeutics for kidney diseases.
Dipyaman Ganguly is an Indian physician-scientist immunologist and cell biologist,currently a Principal Scientist and Swarnajayanthi Fellow at the CSIR-Indian Institute of Chemical Biology (IICB). He heads the Dendritic Cell Laboratory of IICB,popularly known as the Ganguly Lab,where he hosts several researchers involved in research on regulation of innate Immunity and pathogenesis of inflammatory disorders. The Council of Scientific and Industrial Research,the apex agency of the Government of India for scientific research,awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology,one of the highest Indian science awards for his contributions to Medical Sciences in 2022.
Dean Y. Li is the senior vice president of Discovery Sciences and Translational Medicine of Merck &Co. and president-elect of Merck Research Laboratories.
Cheryl Lyn Walker is an American molecular biologist.
Sendurai A. Mani is an Indian-American oncologist and a Molecular Bilogist. He is a fellow of the American Association for the Advancement of Sciences,and Dean's Chair for Translational Oncology at Brown University Warren Alpert Medical School. He is also the associate director for Translational Oncology at the Legorreta Cancer Center at Alpert Medical School,Brown University. Previously,he was a co-director of Metastasis Research Center and co-director,the Center for Stem Cell &Developmental Biology,and a professor of Translational Molecular Pathology at MD Anderson Cancer Center.
Terri Goss Kinzy is an American biochemist,educator and academic administrator.